Related Experiment Video

Updated: Jun 12, 2026

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

International society for antiviral research - 23rd international conference

Vicki L Mason1

  • 1Thomson Reuters, 77 Hatton Garden, London, EC1N 8JS, UK. vicki.mason@thomsonreuters.com

Idrugs : the Investigational Drugs Journal
|May 28, 2010
PubMed

Insights

The 23rd International Antiviral Research Conference showcased novel antiviral therapies. Key developments included HIV entry inhibitors, HBV vaccines, and compounds targeting HCV, CMV, and influenza.

Area of Science:

  • Virology
  • Immunology
  • Pharmacology

Background:

  • The 23rd International Conference on Antiviral Research (ICAR) convened to discuss advancements in antiviral therapeutics.
  • Selected presentations focused on emerging treatments for viral infections including HIV, HBV, HCV, CMV, and influenza.

Framework:

  • The conference report highlights innovative approaches and compounds presented.
  • Key areas included novel drug candidates, vaccine technologies, and small-molecule antiviral discovery.

Implementation:

  • Presentations covered CD4-BFFI, a bifunctional HIV entry inhibitor (Roche Holding AG).
  • A CLDC-HBsAg vaccine for HBV (Juvaris BioTherapeutics Inc/China National Biotec Group) was discussed.
  • ODE-(S)-MPMPA, an anti-HCV compound (University of California San Diego), was featured.
  • Tricin's anti-human CMV activity and Ingavirin's protective effects against influenza A were presented.
  • Prosetta Bioconformatics shared their strategy for identifying small-molecule antivirals.

Implications:

  • These advancements represent significant progress in the development of new antiviral strategies.
  • The diverse range of therapeutic targets and approaches underscores the dynamic nature of antiviral research.
  • Continued research and development in these areas hold promise for combating viral diseases.

More Related Videos

Assembly and Purification of Prototype Foamy Virus Intasomes10:20

Assembly and Purification of Prototype Foamy Virus Intasomes

Published on: March 19, 2018

Related Concept Videos

Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...